GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein
Ming Zhao(National Center of Biomedical Analysis), Jia‐Qing Xing(National Center of Biomedical Analysis), Tao Zhou(National Center of Biomedical Analysis), Tian Xia(Baylor Genetics), Xiaoyao Yin(National Center of Biomedical Analysis), Zhenghong Yuan(Shanghai Medical College of Fudan University), Miao Wang(Beijing Normal University), Tingting Li(Peking University), Yu Yu(Jilin University), Rong Zhang(Huazhong Agricultural University), Tao Li(Shanghai Medical College of Fudan University), Xuemin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Li-Ming Sun(National Center of Biomedical Analysis), Ailing Li(Shanghai Medical College of Fudan University), Yunkai Zhu(Army Medical University)
Cited by 130
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
Mxra8 is a receptor for multiple arthritogenic alphaviruses
|Nature|2018|455